PlainRecalls
FDA Drug Low Class III Terminated

Olanzapine Tablets, 10 mg, packaged in a) 30-count bottles (NDC 62756-554-83), b) 100-count bottles (NDC 62756-554-88), and c) 1000-count bottles (NDC 62756-554-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India, NDC 62756-551-18.

Reported: May 17, 2017 Initiated: March 22, 2017 #D-0701-2017

Product Description

Olanzapine Tablets, 10 mg, packaged in a) 30-count bottles (NDC 62756-554-83), b) 100-count bottles (NDC 62756-554-88), and c) 1000-count bottles (NDC 62756-554-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India, NDC 62756-551-18.

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Details

Units Affected
38,316 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
Olanzapine Tablets, 10 mg, packaged in a) 30-count bottles (NDC 62756-554-83), b) 100-count bottles (NDC 62756-554-88), and c) 1000-count bottles (NDC 62756-554-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India, NDC 62756-551-18.. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 38,316 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).
Which agency issued this recall?
This recall was issued by the FDA Drug on May 17, 2017. Severity: Low. Recall number: D-0701-2017.